FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
January 24, 2021 19:07 ET | Source: Junshi Biosciences Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
Melanoma Research
01/26/2021
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
January 24, 2021 19:07 ET | Source: Junshi Biosciences Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
|
|
01/08/2021
Why Is the Tissue Bank So Important For Melanoma Research?
We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment;…
|
01/08/2021
What is Oral Parity, and Why Does it Matter?
We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
|
11/24/2020
Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma
Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
|
|
06/02/2020
WIM: Emphasizing the Whole Patient and the Whole Physician
By, Vallerie A. Malkin In August of 2017, AIM at Melanoma hosted the inaugural Women in Melanoma Initiative in…
|
01/23/2020
AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University
January 23, 2020 (San Rafael, California)… AIM at Melanoma and AIM at Melanoma Research Foundation announce the opening of…
|
|
11/14/2019
AIM at Melanoma Opens The Third Branch of Fresh Frozen Primary Tissue Bank at at the Knight Cancer Institute at Oregon Health & Science University
AIM AT MELANOMA OPENS THIRD BRANCH OF FRESH FROZEN PRIMARY TISSUE BANK AT THE KNIGHT CANCER INSTITUTE AT OREGON…
|
|
09/09/2019
AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center
September 9, 2019 (San Rafael, California) AIM at Melanoma announces the grand opening of the second branch of the International…
|
|
06/11/2019
The Conversation Has Changed For Stage III Melanoma
Stage III Melanoma—High Risk for Recurrence and (Now) Multiple Options Stage III adjuvant treatment options were for many years limited…
|
04/04/2019
AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center
April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
|
|
Recent Posts
Oct. 08, 2024
Nailing Down on the Ultraviolet Exposure Occurring During the Curing and Drying of a Manicure
Oct. 01, 2024
Summit of Survival: Tobi’s Journey Beyond Melanoma
Oct. 01, 2024
Ways to Give: Monthly Giving
Sep. 24, 2024
Social Awareness and Support Needed for Spouses of Patients Recently Diagnosed With Cancer
Sep. 20, 2024